Bilirubin Conjugate (sodium salt)
|
- $37 - $775
- Product name: Bilirubin Conjugate (sodium salt)
- CAS: 68683-34-1
- MF: C37H44N6Na2O10S2
- MW: 842.889
- EINECS:272-072-3
- MDL Number:MFCD00044931
- Synonyms:disodium 2,2'-[(1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-2,17-divinyl-21H-biline-8,12-diyl)bis[(1-oxopropane-3,1-diyl)imino]]bis[ethane-1-sulphonate] ;Ditaurobilirubin disodium salt;2,2'-[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-diyl)bis[(1-oxo-3,1-propanediyl)imino]]bis(ethanesulfonic acid sodium) salt;2,2'-[[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline)-8,12-diyl]bis[(1-oxo-3,1-propanediyl)imino]]bis(ethanesulfonic acid sodium) salt;2,2'-[[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline)-8,12-diyl]bis[(1-oxo-3,1-propanediyl)imino]]bis[ethanesulfonic acid sodium] salt;Bilirubin Conjugate (sodium salt);disodium:2-[3-[5-[(E)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-2-[[5-[(E)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-[3-oxo-3-(2-sulfonatoethylamino)propyl]-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoylamino]ethanesulfonate;Sodium dithiocarbamate bilirubin / conjugated bilirubin
10 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Cayman Chemical
Package
- 5MG
- 10mg
- 50mg
- 100mg
- 500mg
- ManufacturerAK Scientific
- Product number9653BB
- Product descriptionDisodium;2-[3-[5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-2-[[5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-[3-oxo-3-(2-sulfonatoethylamino)propyl]-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoylamino]ethanesulfonate
- Packaging100mg
- Price$276
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberING0025871
- Product descriptionBILIRUBIN CONJUGATE 95.00%
- Packaging5MG
- Price$450.43
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging500mg
- Price$704
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging500mg
- Price$775
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging10mg
- Price$37
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging10mg
- Price$41
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging50mg
- Price$108
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging50mg
- Price$119
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging100mg
- Price$161
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number17170
- Product descriptionBilirubin Conjugate (sodium salt) ≥95%
- Packaging100mg
- Price$178
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 9653BB | Disodium;2-[3-[5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-2-[[5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-[3-oxo-3-(2-sulfonatoethylamino)propyl]-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoylamino]ethanesulfonate | 100mg | $276 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | ING0025871 | BILIRUBIN CONJUGATE 95.00% | 5MG | $450.43 | 2021-12-16 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 500mg | $704 | 2024-03-01 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 500mg | $775 | 2026-04-30 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 10mg | $37 | 2024-03-01 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 10mg | $41 | 2026-04-30 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 50mg | $108 | 2024-03-01 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 50mg | $119 | 2026-04-30 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 100mg | $161 | 2024-03-01 | Buy |
| Cayman Chemical | 17170 | Bilirubin Conjugate (sodium salt) ≥95% | 100mg | $178 | 2026-04-30 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMF: 0.25 mg/ml; DMSO: 10 mg/ml; Water: 5 mg/ml
form :A crystalline solid
color :Orange to red
InChIKey :IQKDYMAMJBFOQJ-MWABKKRNSA-L
SMILES :C1(CCC(=O)NCCS(=O)(=O)[O-])C(C)=C(/C=C2/C(C)=C(C=C)C(=O)N/2)NC=1CC1=C(CCC(=O)NCCS(=O)(=O)[O-])C(C)=C(/C=C2/C(C=C)=C(C)C(=O)N/2)N1.[Na+].[Na+]
EPA Substance Registry System :Ethanesulfonic acid, 2,2'-[(2,17-diethenyl-1,10,11,19,22,23-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-diyl)bis[(1-oxo-3,1-propanediyl)imino]]bis-, disodium salt (68683-34-1)
solubility :DMF: 0.25 mg/ml; DMSO: 10 mg/ml; Water: 5 mg/ml
form :A crystalline solid
color :Orange to red
InChIKey :IQKDYMAMJBFOQJ-MWABKKRNSA-L
SMILES :C1(CCC(=O)NCCS(=O)(=O)[O-])C(C)=C(/C=C2/C(C)=C(C=C)C(=O)N/2)NC=1CC1=C(CCC(=O)NCCS(=O)(=O)[O-])C(C)=C(/C=C2/C(C=C)=C(C)C(=O)N/2)N1.[Na+].[Na+]
EPA Substance Registry System :Ethanesulfonic acid, 2,2'-[(2,17-diethenyl-1,10,11,19,22,23-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-diyl)bis[(1-oxo-3,1-propanediyl)imino]]bis-, disodium salt (68683-34-1)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




